Are you joining us on March 28-29 in Dallas to learn from our world-renowned afib experts on how to get in rhythm and stay in rhythm? Afib patients are coming from all over to be here, and we hope you can join us, too. Learn more about the conference, and register, at: Afib Patients from …
Read More
Big news! Boehringer Ingelheim has submitted an application to the FDA requesting accelerated approval for idarucizumab, the reversal agent for Pradaxa (dabigatran). See: Boehringer Ingelheim Submits Biologics License Application to FDA for Idarucizumab*, Investigational Specific Reversal Agent for Pradaxa® Additionally, they have submitted for marketing approval by Health Canada and the European Medicines Agency (EMA). See: Boehringer …
Read More
Exciting News! AliveCor is giving away AliveCor® Heart Monitors to the first 100 people that enter and pick up their AliveCor at our Get in Rhythm, Stay in Rhythm AF Patient Conference! With conference early registration at ONLY $79, and the AliveCor Heart Monitor costing $75, this is pretty much a no-brainer! Register Today — …
Read More
Plan to join us March 28-29, 2015, at the StopAfib.org National Atrial Fibrillation Patient Conference to hear our rock-star cast of afib experts share ways for you to get in rhythm and stay in rhythm. This is a not-to-be-missed event—take a look at who’s speaking! The conference will be held at the Hyatt Regency DFW …
Read More
The VICTORY AF (Evaluation of Multielectrode Phased RF Technology in Persistent AF) Trial, sponsored by Medtronic, is studying patients undergoing a catheter ablation with Medtronic's Phased Radiofrequency (RF) system. To learn more, see: VICTORY AF Trial Studies Phased Radiofrequency (RF) System for Persistent and Longstanding Persistent Atrial Fibrillation
Read More
Atrial fibrillation is the most common irregular heart rhythm that starts in the atria. While it is often a mere annoyance, it can also be responsible for life-threatening medical emergencies that result in cardiac arrest, stroke and sudden death. Take advantage of the opportunity to get your atrial fibrillation questions answered by afib experts from …
Read More
Biosense Webster, Inc. and StopAfib.org have teamed up to raise awareness of atrial fibrillation and available treatment options through Get SMART About AfibSM, an interactive web experience. Learn more at: Biosense Webster Teams Up with StopAfib.org to Challenge Americans to Get SMART About AfibSM
Read More
MedQuery Inc, a national medical market research company that collaborates with pharmaceutical and medical device companies, is looking for people who have been diagnosed with Atrial Fibrillation to participate in a face to face interview research study in NEW YORK on October 7th and 8th. This study is aimed at improving AF treatment and understanding …
Read More
Today, at the European Society of Cardiology Congress in Barcelona, it was reported that even though 80% of atrial fibrillation patients who should be on anticoagulants (according to their CHA2DS2-VASc score) are on anticoagulants, death rates at one year are still high. Most of those deaths are due to cardiovascular causes. The risk factors predicting …
Read More
New research from the University of California at San Francisco indicates that atrial flutter can be cured through catheter ablation and doing so can reduce the risk for atrial fibrillation. To learn more, see: Catheter Ablation a First-Line Treatment for Atrial Flutter
Read More